4.7 Article

Synthesis and antitubercular activities of substituted benzoic acid N′-(substituted benzylidene/furan-2-ylmethylene)-N-(pyridine-3-carbonyl)-hydrazides

Journal

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 45, Issue 12, Pages 6085-6089

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2010.08.030

Keywords

Benzoic acid hydrazones; Synthesis; Antitubercular; MIC

Ask authors/readers for more resources

A series of benzoic acid hydrazones and its nicotinyl derivatives (1-10) were prepared and evaluated for their antitubercular activity towards a strain of Mycobacterium tuberculosis (MTB). The structures of newly synthesized compounds were confirmed by infrared (IR) and H-1-nuclear magnetic resonance (NMR) spectral data and elemental analysis. The in vitro antitubercular activity of synthesized compounds against MTB was carried out in Middlebrook 7H11agar medium supplemented with OADC by agar dilution method. The antitubercular activity results indicated that nicotinic acid N-(3,5-dinitrobenzoyl)-N'-(4-methoxy-benzylidene)-hydrazide (1) is the most potent among the synthesized compounds with MIC of 3.5 x 10(-3) mu M. (C) 2010 Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Multifaceted 3D-QSAR analysis for the identification of pharmacophoric features of biphenyl analogues as aromatase inhibitors

Laxmi Banjare, Yogesh Singh, Sant Kumar Verma, Atul Kumar Singh, Pradeep Kumar, Shashank Kumar, Akhlesh Kumar Jain, Suresh Thareja

Summary: This study investigated a series of biphenyl bearing molecules with a wide range of aromatase inhibitory activity using a multifaceted approach including 3D-QSAR analysis, molecular docking, molecular dynamic simulations, and pharmacophore mapping. The results showed that the force field-based 3D-QSAR model was the best in terms of fitness, and the generated pharmacophoric features were able to explain the variation in biological activity. The findings offer guidance for designing potent biphenyl derivatives as aromatase inhibitors.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Biochemistry & Molecular Biology

Molecular dynamics and 3D-QSAR studies on indazole derivatives as HIF-1α inhibitors

Yogesh Singh, Kulkarni Swanand Sanjay, Pradeep Kumar, Satwinder Singh, Suresh Thareja

Summary: This study investigated the pharmacophoric features and inhibitory potency of HIF-1 alpha inhibitors through three-dimensional quantitative structural activity relationship and pharmacophore mapping. It was found that indazole derivatives have the potential to be effective inhibitors of HIF-1 alpha, and molecular docking and molecular dynamics simulations confirmed the binding efficiency and stability of the most potent compound. The developed models and analysis techniques can be used to design selective lead molecules for the treatment of cancer.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Review Oncology

Current Insights into the Role of BRAF Inhibitors in Treatment of Melanoma

Ankit Kumar Singh, Adarsh Kumar, Suresh Thareja, Pradeep Kumar

Summary: Melanomas, accounting for only 4% of skin cancers, have a mortality rate higher than 50% of other skin cancers. Genetic and environmental alterations are risk factors for melanoma development. The RAS/RAF/MEK/ERK or MAPK pathway is activated in melanoma, with BRAF mutations found in 80-90% of cases. Understanding melanoma pathogenesis, BRAF conformations, and the problems with current FDA-approved inhibitors is crucial for new drug discovery and improving treatment effectiveness.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2023)

Review Chemistry, Medicinal

Synthetic PARP-1 Inhibitors Reported During the Last Decade

Maneesh Guleria, Pradeep Kumar, Suresh Thareja

Summary: Background: Cancer is the second-leading cause of death worldwide, with an estimated 9.6 million deaths in 2018. PARP-1 is an enzyme and protein family involved in various cellular processes, including DNA repair and gene regulation. This article summarizes synthetic PARP-1 inhibitors reported in the past decade and highlights the need for further research on effective and safe PARP-1 inhibitors for cancer treatment.

LETTERS IN DRUG DESIGN & DISCOVERY (2023)

Review Chemistry, Medicinal

A Review of Phytoconstituents as Antibacterial Agents

Gunjan Bisht, Ankit Kumar Singh, Adarsh Kumar, Pradeep Kumar

Summary: Background bacteria lead to various infectious diseases and millions of deaths each year. Plant-derived secondary metabolites possess antibacterial activity and can decrease resistance through inhibition of biofilm formation, efflux pump inhibition, attenuation of bacterial virulence, and immunomodulation activity.

NATURAL PRODUCTS JOURNAL (2023)

Article Biochemistry & Molecular Biology

Flavonoids as promising anticancer agents: an in silico investigation of ADMET, binding affinity by molecular docking and molecular dynamics simulations

Avadh Biharee, Arpita Yadav, Kailash Jangid, Yogesh Singh, Swanand Kulkarni, Devesh M. Sawant, Pradeep Kumar, Suresh Thareja, Akhlesh Kumar Jain

Summary: Flavonoids have shown potential as excellent anti-tubulin agents for cancer treatment, and this study provides strong evidence for their effectiveness through in silico ADMET analysis, molecular docking, and molecular dynamics simulation.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Review Oncology

Synthetic Methodologies and SAR of Quinazoline Derivatives as PI3K Inhibitors

Aditya Raj, Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Suresh Thareja, Pradeep Kumar

Summary: PI3K controls cellular functions and is an important target for anticancer treatment. Quinazoline derivatives have shown promise as PI3K inhibitors and several compounds are currently in clinical trials. This study provides information on synthetic approaches, mechanisms of action, and structure-activity relationship analysis of quinazoline derivatives to aid in the design of better and isoform-selective PI3K inhibitors for researchers in the field.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

Recent Advancements in the Discovery of MDM2/MDM2-p53 Interaction Inhibitors for the Treatment of Cancer

Neha Bhatia, Rakesh Khator, Swanand Kulkarni, Yogesh Singh, Pradeep Kumar, Suresh Thareja

Summary: The discovery of MDM2 and MDM2-p53 interaction inhibitors has revolutionized anticancer research due to their involvement in about 50% of cancer cases globally. In addition to inhibiting MDM2, targeting the interaction between MDM2 and p53 has proven to be an effective strategy for anticancer drug development. Both natural and synthetic molecules have shown promising MDM2 inhibitory potential. This review focuses on the pathophysiology of the MDM2-p53 interaction loop, characteristics of the active site, and the efficacy of various inhibitors from recent patents.

CURRENT MEDICINAL CHEMISTRY (2023)

Review Biochemistry & Molecular Biology

Bacteriophages Concept and Applications: A Review on Phage Therapy

Rasti Sahu, Ankit Kumar Singh, Adarsh Kumar, Kuldeep Singh, Pradeep Kumar

Summary: The nature of phages was controversial, but in 1940 the dispute was resolved and their activity and application continued to develop in the Soviet Union and Eastern Europe. Bacteriophages were first used in 1919 to treat bacterial illnesses. Bacteriophages have different levels of complexity, ranging from simple spherical viruses to more complicated ones with larger genome sizes.

CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2023)

Review Biochemistry & Molecular Biology

Metal Complexes in Cancer Treatment: Journey So Far

Ankit Kumar Singh, Adarsh Kumar, Harshwardhan Singh, Pankaj Sonawane, Prateek Pathak, Maria Grishina, Jagat Pal Yadav, Amita Verma, Pradeep Kumar

Summary: Metal complexes have attracted attention in cancer therapy due to their unique characteristics. The discovery of cisplatin in 1965 was a significant breakthrough and led to the development of metal-based anticancer drugs. Many metal-based compounds are being studied for their potential anticancer properties, with some already approved by the FDA or undergoing clinical trials. This study highlights the mode of action of metallic complexes and reviews the progress of metal-based complexes with potential anticancer activities, such as platinum, ruthenium, and iron.

CHEMISTRY & BIODIVERSITY (2023)

Review Chemistry, Medicinal

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective

Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas, Pradeep Kumar

Summary: Cancer is a major healthcare challenge worldwide, calling for the development of safer and target-specific anticancer drugs. This study summarizes the use of nitrogen-containing heterocycles in cancer treatment, providing insights into their pharmacological properties and mechanisms of action.

PHARMACEUTICALS (2023)

Review Biochemistry & Molecular Biology

Current insights and molecular docking studies of HIV-1 reverse transcriptase inhibitors

Ankit Kumar Singh, Adarsh Kumar, Sahil Arora, Raj Kumar, Amita Verma, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid Emwas, Pradeep Kumar

Summary: This review examines the structure, replication cycle, reverse transcription, and drug targets of HIV-1. It focuses on nucleoside reverse transcriptase inhibitors (NRTIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs), including their mechanisms of action, FDA-approved drugs, drugs in clinical trials, resistance and adverse effects, molecular docking studies, and highly active antiretroviral therapy (HAART).

CHEMICAL BIOLOGY & DRUG DESIGN (2023)

Article Biochemistry & Molecular Biology

Phytochemical Profiling and Pharmacological Evaluation of Leaf Extracts of Ruellia tuberosa L.: An In Vitro and In Silico Approach

Akanksha Sharma, Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, K. Jayaram Kumar, Pradeep Kumar

Summary: This study evaluated the photoprotective, antioxidant, and antibacterial properties of Ruellia tuberosa leaf extracts. The results showed that the methanol extract of R. tuberosa had high total phenolic content, while the acetic acid extract had the highest total flavonoid content. The methanol extract exhibited effective antioxidant activity and the methanol, ethyl acetate, and methanol-chloroform extracts showed effective antibacterial activity against E. coli. In silico docking studies identified phytochemicals that showed good docking scores and drug likeness properties against various proteins.

CHEMISTRY & BIODIVERSITY (2023)

Article Biochemistry & Molecular Biology

Design, one-pot synthesis, computational and biological evaluation of diaryl benzimidazole derivatives as MEK inhibitors

Teja Ram, Ankit Kumar Singh, Prateek Pathak, Adarsh Kumar, Harshwardhan Singh, Maria Grishina, Jurica Novak, Pradeep Kumar

Summary: MEK mutations are common in various types of cancer, and the design of compounds with structural resemblance to FDA-approved MEK inhibitors has shown promise. Through chemical synthesis and computational studies, compound S15 was found to be the most potent against cancer cells, while compounds S1 and S5 were comparable to the standard drug trametinib.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Biochemistry & Molecular Biology

Oxazoline/amide derivatives against M. tuberculosis: experimental, biological and computational investigations

Priyanka Bajpai, Ankit Kumar Singh, Shivanada Kandagalla, Phool Chandra, Vimlendu Kumar Sah, Pradeep Kumar, Maria Grishina, Om Prakash Verma, Prateek Pathak

Summary: Tuberculosis is a deadly disease that claims the lives of approximately 2 million people annually. This study synthesized and tested the anti-tuberculosis activity of different oxazoline/amide derivatives. Based on their computational and biological study, two compounds (2d and 3e) showed comparable antitubercular activity to the standard drug.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2023)

Article Chemistry, Medicinal

Highly potent dual-targeting angiotensin-converting enzyme 2 (ACE2) and Neuropilin-1 (NRP1) peptides: A promising broad-spectrum therapeutic strategy against SARS-CoV-2 infection

Shuang Mei, Su Jiang, Yuting Wang, Han Jing, Peng Yang, Miao-Miao Niu, Jindong Li, Kai Yuan, Yan Zhang

Summary: This study identifies a dual-targeting peptide, AP-1, that effectively inhibits variants of concern (VOCs) of SARS-CoV-2 without impairing host cell viability. The findings suggest that AP-1 could be a promising broad-spectrum agent for treating emerging VOCs of SARS-CoV-2.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of proteolysis-targeting chimera targeting undruggable proteins using a covalent ligand screening approach

Hyeonjun Lee, Ju Yeon Lee, Hyunsoo Jang, Hye Young Cho, Minhee Kang, Sang Hyun Bae, Suin Kim, Eunji Kim, Jaebong Jang, Jin Young Kim, Young Ho Jeon

Summary: By using liquid chromatography-tandem mass spectrometry and nuclear magnetic resonance experiments, we identified new chemical moieties that bind to the target sites of the protein of interest, allowing for reversible binding and protein degradation. This method has the potential to expand the application of PROTAC technology.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A pro-death autophagy-based nanoplatform for enhancing antitumour efficacy with improved immune responses

Yingying Li, Xiyou Du, Xinru Kong, Yuelin Fang, Zhijing He, Dongzhu Liu, Hang Wu, Jianbo Ji, Xiaoye Yang, Lei Ye, Guangxi Zhai

Summary: This study proposes a novel nanoplatform based on the autophagy cascade to overcome the obstacles in chemo-immunotherapy. The platform combines chemotherapy and starvation therapy to initiate pro-death autophagy and enhance antigen presentation, while also remodeling the immunosuppressive tumor microenvironment. Furthermore, the study discovers a new therapeutic direction for the respiration inhibitor 3-bromopyruvic acid (3BP) in cancer treatment. Overall, this study offers an opportunity to improve antitumor efficacy and boost immune responses.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

A novel scaffold long-acting selective estrogen receptor antagonist and degrader with superior preclinical profile against ER plus breast cancer

Bingsi Wang, Mingxu Ma, Yusen Dai, Pengfei Yu, Liang Ye, Wenyan Wang, Chunjie Sha, Huijie Yang, Yingjie Yang, Yunjing Zhu, Lin Dong, Shujuan Wei, Linlin Wang, Jingwei Tian, Hongbo Wang

Summary: Breast cancer is a common malignant tumor in women, and drug resistance remains a clinical challenge. In this study, a novel compound, G-5b, was developed with potent antagonistic and degradation activities comparable to the current drug fulvestrant. G-5b also showed improved stability and solubility. Mechanistically, G-5b engages the proteasome pathway to degrade ER, inhibiting the ER signaling pathway and inducing apoptosis and cell cycle arrest. In animal models, G-5b exhibited superior pharmacokinetics and pharmacodynamics properties. Overall, G-5b is a promising long-acting SERD worthy of further investigation and optimization.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

HDAC specificity and kinase off-targeting by purine-benzohydroxamate anti-hematological tumor agents

Karoline B. Waitman, Larissa C. de Almeida, Marina C. Primi, Jorge A. E. G. Carlos, Claudia Ruiz, Thales Kronenberger, Stefan Laufer, Marcia Ines Goettert, Antti Poso, Sandra V. Vassiliades, Vinicius A. M. de Souza, Monica F. Z. J. Toledo, Neuza M. A. Hassimotto, Michael D. Cameron, Thomas D. Bannister, Leticia Costa-Lotufo, Joa o A. Machado-Neto, Mauricio T. Tavares, Roberto Parise-Filho

Summary: A series of hybrid inhibitors combining pharmacophores of known kinase inhibitors and benzohydroxamate HDAC inhibitors were synthesized and evaluated for their anticancer activity and pharmacokinetic properties. Compounds 4d-f exhibited promising cytotoxicity against hematological cells and moderate activity against solid tumor models. Compound 4d showed potent inhibition of multiple kinase targets and had stable interactions with HDAC and members of the JAK family. These compounds showed selective cytotoxicity with minimal effects on non-tumorigenic cells and favorable pharmacokinetic profiles.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Unexpected rearrangement of ivermectin in the synthesis of new derivatives with trypanocidal and antiplasmodial activities

Michal Sulik, Diana Fontinha, Dietmar Steverding, Szymon Sobczak, Michal Antoszczak, Miguel Prudencio, Adam Huczynski

Summary: This study describes the synthesis of the first-in-class ivermectin derivatives obtained through derivatization of the C13 position, along with the unexpected rearrangement of the macrolide ring. These derivatives show potential for antiparasitic activity and are important for the development of new antiparasitic agents.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Novel ligustilide derivatives target quorum sensing system LasR/LasB and relieve inflammatory response against Pseudomonas aeruginosa infection

Jun Liu, Qiu-Xian Chen, Wen-Fu Wu, Dong Wang, Si -Yu Zhao, Jia-Hao Li, Yi-Qun Chang, Shao-Gao Zeng, Jia-Yi Hu, Yu-Jie Li, Jia-Xin Du, Shu-Meng Jiao, Hai-Chuan Xiao, Qiang Zhang, Jun Xu, Jian-Fu Zhao, Hai -Bo Zhou, Yong-Heng Wang, Jian Zou, Ping-Hua Sun

Summary: A new anti-infective drug strategy has been discovered to attenuate virulence and modulate inflammation caused by drug-resistant Pseudomonas aeruginosa infections. Compound 5f inhibits biofilm formation, macrophage migration, and inflammatory response induced by P. aeruginosa, showing potential as a novel candidate against drug-resistant infections.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Design and synthesis of pterostilbene derivatives bearing triazole moiety that might treat DSS-induced colitis in mice through modulation of NF-KB/ MAPK signaling pathways

Liuzeng Chen, Ke Wang, Lingyun Wang, Wei Wang, Lifan Wang, Jia Li, Xiaohan Liu, Mengya Wang, Banfeng Ruan

Summary: In this study, a series of novel anti-inflammatory compounds were designed and synthesized based on the natural product pterostilbene skeleton. Among them, compound 8 showed the highest activity and exhibited its effects through inhibition of pro-inflammatory cytokines by blocking the NF-KB/MAPK signaling pathway. Compound 8 also demonstrated a good relieving effect on acute colitis in mice and showed good safety in acute toxicity experiments.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)

Article Chemistry, Medicinal

Discovery of 4-(N-dithiobenzyl piperazine)-1,8-naphthalimide as a potent multi-target antitumor agent with good efficacy, limited toxicity, and low resistance

Si-Min Liang, Gui-Bin Liang, Hui-Ling Wang, Hong Jiang, Xian-Li Ma, Jian-Hua Wei, Ri-Zhen Huang, Ye Zhang

Summary: A series of novel multi-target antitumor agents were designed, synthesized, and evaluated. Some compounds exhibited significant antitumor activity and one compound showed excellent efficacy, limited toxicity, and low resistance. Further mechanism studies revealed that the compound exerted antitumor effects through multiple pathways.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2024)